台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide)
0.1.1 - ci-build
台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide) - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://hapi.fhir.tw/fhir/ValueSet/lf-OthChem-valueset | Version: 0.1.1 | |||
| Active as of 2024-08-01 | Computable Name: LFOthChemVS | |||
Other Chemotherapy Value Set
References
Generated Narrative: ValueSet lf-OthChem-valueset
https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem
Generated Narrative: ValueSet
Expansion based on codesystem 外院化學治療代碼系統 v0.1.1 (CodeSystem)
This value set contains 19 concepts
| Code | System | Display |
| 00 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | (1)未接受化學治療，化學治療非首次療程的一部份 (2)由屍體解剖時才診斷為癌症 |
| 01 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 接受全身性化學治療 |
| 02 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 接受全身性化學治療，且只有一種化學藥物。(僅適用於 2017(含)診斷年之前的個案) |
| 03 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 接受全身性化學治療，且超過一種以上的化學藥物。(僅適用於 2017(含)診斷年之前 的個案) |
| 04 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案原發部位僅接受局部動脈栓塞化學治療(TACE) |
| 05 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案原發部位接受局部動脈栓塞化學 (TACE)及全身性化學治療 |
| 06 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案原發部位接受局部動脈栓塞化學 (TACE)及其他局部性化學治療 |
| 07 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案原發部位接受局部動脈栓塞化學 (TACE)、其他局部性及全身性化學治療 |
| 08 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案僅接受局部性化學治療(不包含TACE) (1)肋膜腔注射 (2)心包膜腔注射 (3)腹腔內注射 (4)膀胱灌注 (5)脊髓腔內注射(intrathecal) (6)其他局部化學治療(例如：BCNU wafer implantation) |
| 09 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 個案同時接受全身性及局部性化學治療(不包含TACE) |
| 10 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 肝轉移個案接受局部動脈栓塞化學治療(TACE) |
| 11 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 肝轉移個案接受局部動脈栓塞化學(TACE)及全身性化學治療 |
| 12 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 肝轉移個案接受局部動脈栓塞化學治療(TACE)及其他局部性化學治療 |
| 13 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 肝轉移個案接受局部動脈栓塞化學治療(TACE)、其他局部性及全身性化學治療 |
| 20 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 僅接受臨床試驗化學治療 |
| 21 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 同時接受化學治療(全身性或/與局部性)及臨床試驗化學治療 |
| 30 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 僅接受雙盲試驗化學治療 |
| 31 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | 同時接受化學治療(全身性或/與局部性)及雙盲試驗化學治療 |
| 99 | https://hapi.fhir.tw/fhir/CodeSystem/lf-OthChem-codesystem | (1)由於病歷未記載，所以不知道化學治療是否有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症 |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |